NCT00789711 - An Observational Study to Compare the Safety and Effectiveness of NovoMix® 30 and Levemir™ for the Treatment of Diabetes | Biotech Hunter

Enrollment

3,131

Participants

Timeline

Start Date

November 30, 2008

Primary Completion Date

August 31, 2009

Study Completion Date

August 31, 2009

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Interventions

DRUG

biphasic insulin aspart 30

Evaluation of the safety profile and effectiveness of biphasic insulin aspart 30 in the treatment of diabetes mellitus under normal clinical practice conditions in the Philippines

DRUG

insulin detemir

Evaluation of the safety profile and effectiveness of insulin detemir in the treatment of diabetes mellitus under normal clinical practice conditions in the Philippines

Trial Locations (1)

1605

Novo Nordisk Investigational Site, Manila